Back to Journals » Clinical Ophthalmology » Volume 2 » Issue 4

Intravitreal bevacizumab has initial clinical benefit lasting eight weeks in eyes with neovascular age-related macular degeneration

Total article views   Abstract views HTML views PDF downloads Totals
4,517 Dovepress* 4,517 0+ 1,513 4,517
Totals 4,517 0 1,513 4,517
*Since 5 December 2008
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
1 0 0 0 0 1

View citations on Google Scholar